Get the Stockscreener App
32.79
0.00%
0.00
After Hours:
32.79
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Piper Sandler Downgrades Amphastar Pharmaceuticals (NASDAQ:AMPH) to Neutral - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Growth in Short Interest - MarketBeat
Piper Sandler Downgrades Amphastar Pharmaceuticals (AMPH) - MSN
Piper Sandler cuts Amphastar stock rating, slashes price target By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownHere's What Happened - MarketBeat
Market Resilience: Amphastar Pharmaceuticals Inc (AMPH) Finishes Weak at 33.39, Down -4.24 - The Dwinnex
This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga India
Piper Sandler Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $36 From $66 - Marketscreener.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Neutral Rating by Piper Sandler - MarketBeat
Long Term Trading Analysis for (AMPH) - Stock Traders Daily
Boston Trust Walden Corp Purchases 439,281 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler cuts Amphastar stock rating, slashes price target - MSN
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week LowHere's What Happened - MarketBeat
Amphastar stock hits 52-week low at $34.08 amid market challenges - Investing.com India
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference - ACCESS Newswire
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $46 -February 03, 2025 at 10:16 am EST - Marketscreener.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Pacer Advisors Inc. - MarketBeat
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021 - ACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - ACCESS Newswire
(AMPH) Technical Data - Stock Traders Daily
Amphastar Receives FDA Approval for Ganirelix Acetate Injection - ACCESS Newswire
Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock - Simply Wall St
Assenagon Asset Management S.A. Sells 5,956 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 10.3% in December - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowTime to Sell? - MarketBeat
Amphastar stock hits 52-week low at $34.6 amid market challenges - MSN
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 2.4%Should You Sell? - MarketBeat
Dextrose Injection Market Size, Share & Trending Opportunities - WICZ
Dextrose Injection Market Size, Share & Trending Opportunities (2024-2031) | Pfizer Inc., Amphastar Pharmaceuticals Inc. - EIN News
Trend Tracker for (AMPH) - Stock Traders Daily
Oversold Conditions For Amphastar Pharmaceuticals (AMPH) - Nasdaq
Amphastar stock hits 52-week low at $34.85 amid market challenges - Investing.com Nigeria
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 4.6%What's Next? - MarketBeat
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - AccessWire
Amphastar stock hits 52-week low at $34.85 amid market challenges By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals: Cheap With Caveats (NASDAQ:AMPH) - Seeking Alpha
These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Reasonably Well - Simply Wall St
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Expands By 6.1% - Defense World
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Increases By 6.1% - MarketBeat
Amphastar stock hits 52-week low at $36.55 amid market challenges - Investing.com Australia
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year LowHere's Why - MarketBeat
Amphastar stock hits 52-week low at $36.55 amid market challenges By Investing.com - Investing.com South Africa
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
New Strong Sell Stocks for December 31st - Yahoo Finance
Principal Financial Group Inc. Lowers Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):